HRTX- Heron Therapeutics, Inc. /de/

Name: Heron Therapeutics, Inc. /de/ Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

HRTX sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Compare Health Care sector insider flows →

Insider Ownership

Role	Insider	Shares	Value	30d
VP	Forbes William P	245.0K	-	-
COO	Hensley Mark Earl	179.8K	-	-
Dir	Morgan Adam	123.7K	-	-
CEO	Collard Craig A	69.0K	-	-
Dir	Cusack Thomas	54.0K	-	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 8, 2025	Morgan Adam	Director	Buy	1,766,546	$1.50	$2,649,819.00	+25.3%	-16.7%	-62.9%
Aug 8, 2025	Rubric Capital Management LP	10% Owner	Buy	2,387,225	$1.50	$3,580,837.50	+8.9%	-16.7%	-62.9%
Nov 17, 2023	Forbes William P49	EVP, Chief Development Officer	Buy	25,000	$1.09	$27,250.00	+46.3%	+164.2%	+9.2%
Nov 16, 2023	Forbes William P49	EVP, Chief Development Officer	Buy	50,000	$0.94	$46,995.00	+1,250%	+196.7%	+29.8%
Nov 16, 2023	Collard Craig A	Chief Executive Officer	Buy	150,000	$0.92	$137,970.00	+411.0%	+196.7%	+29.8%
Nov 16, 2023	Duarte Ira	EVP, Chief Financial Officer	Buy	85,000	$0.89	$75,599.00	New	+196.7%	+29.8%
Jul 21, 2023	Morgan Adam	Director	Buy	2,486,744	$1.37	$3,406,839.28	+55.3%	-53.8%	+135.5%
May 3, 2022	Manhard Kimberly80	EVP, Drug Development	Sell	1,504	$4.76	$7,153.63	-12.2%	-42.3%	-50.9%
Dec 21, 2021	Johnson Craig A79	Director	Sell	250	$9.73	$2,431.93	-8.1%	-47.0%	-72.2%
Dec 21, 2021	Christian Waage75	Director	Sell	300	$9.73	$2,920.35	-8.6%	-47.0%	-72.2%

Understand these filings

How to Read SEC Form 4 Filings →Understanding Insider Buying Signals →What is Insider Trading? A Complete Guide →Cluster Buying: When Multiple Insiders Buy Together →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC